Complete response to erlotinib treatment in brain metastases from recurrent NSCLC. (Q42721653)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Complete response to erlotinib treatment in brain metastases from recurrent NSCLC (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

C S L Lai

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

C Boshoff

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

M Falzon

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396957%20AND%20SRC:MED&resulttype=core&format=json

Erlotinib in lung cancer - molecular and clinical predictors of outcome

15 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2080696

Erlotinib in previously treated non-small-cell lung cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2080696

Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2080696

A small molecule-kinase interaction map for clinical kinase inhibitors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2080696

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC).

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2080696

16 August 2018

Identifiers

DOI

10.1136/THX.2005.052233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16396957%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference